c ebpβ-lip drug

c ebpβ-lip drug Frontiers Transcriptional Control of COX-2 via

Name: c ebpβ-lip drug Frontiers Transcriptional Control of COX-2 via
Brand: ldesquadrias.com.br
SKU: 83572925665
Price: 20.59 USD
Availability: InStock
Rating: 4.5697 (23 reviews)

Transcriptional Control of COX 2 via C EBP Arteriosclerosis, Thrombosis, and Vascular Biology C EBP regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages Science Immunology C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology C EBP Antibody Sampler Kit Cell Signaling Technology C EBP LIP mediated activation of the malate aspartate shuttle sensitizes cells to glycolysis inhibition ScienceDirect Purified anti C EBP beta 2 isoforms C EBP beta, LAP Antibody anti C EBP beta A16

SKU: 83572925665 · From ldesquadrias.com.br

4.6

USD20.59 USD42.59

Pay in 4 interest-free payments of $5.15 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

L- , :

c ebp-lip drug Frontiers Transcriptional Control of COX-2 via

Hepatocellular carcinoma Hepatocellular carcinoma (HCC), the most frequent primary liver malignancy, accounts for over 90% of all liver cancer cases

doi: 10.1111/j.1365-2109.2009.02374.x 40 UbohF

Significant reductions in both LPS-induced nitric oxide production and inducible nitric oxide synthase expression were observed when 6-shogaol, 1-dehydro-10-gingerdione, and 10-gingerdione were applied (229)